Adaptive Servo-Ventilation and the Serve-Hf Trial: Implications in Heart Failure with Reduced Ejection Fraction
DOI:
https://doi.org/10.24950/rspmi/Revisao/101/18/2/2019Keywords:
Heart Failure, Systolic, Intermittent Positive-Pressure Breathing, Positive-Pressure Respiration, Sleep Apnea, Central, Ventricular Function, LeftAbstract
Adaptive servo ventilation is a type of non-invasive ventilation device, using oscillatory positive airway pressure to treat
central sleep apnoea. Central sleep apnoea is a common
entity in heart failure patients. The SERVE HF trial was an international controlled and randomized study, which demonstrates the hazard effects of this device therapy in HF patients
with reduced ejection fraction. Some methodological issues
are being raised about the consistency of this study. Ongoing
trials could help us, in the future, to definitely define the risks
and the benefits of adaptive servo ventilation device therapy
Downloads
References
Artz M, Woehrle H, Oldenburg O, Graml A, Suling A, Erdmann E, et al. Prevalence and predictors of sleep disorder breathing in patients with stable chronic heart failure: the SchlaHF registry. JACC Heart Fail. 2016;4:116- 25. doi: 10.1016/j.jchf.2015.09.014
Spicuzza L, Caruso D, Maria G. Obstructive Sleep apnea syndrome and its management. Ther Adv Chronic Dis. 2015;6:273-83.
Muza R. Central Sleep Apnea- a clinical review. J Thorac Dis. 2015;7:930- 7. doi: 10.3978/j.issn.2072-1439.2015.04.45.
Nicholas WT. Sleep related breathing disorders- Nosological classification, definition, epidemiology. Regensburg: European Sleep Research Society; 2014.
Sin DD, Fitzgerald F, Parker JD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. 1999; 160:1101-06.
Javaheri S, Dempsey JA. Central sleep apnea. Compr Physiol. 2013; 3:141-63
Naughton M, Benard D, Tam A, Rutherford R, Bradley TD. Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis. 1993; 148:330-8.
Naughton MT, Liu PP, Bernard DC, Goldstein RS, Bradley TD. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med. 1995;151:92-7.
Javaheri S, Shukula R, Ziegler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol. 2007; 49:2028-34. doi: 10.1016/j.jacc.2007.01.084
Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med. 1999; 341: 949-54.
Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med. 2001; 164: 2147-65.
Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP. Pathophysiology of sleep apnea. Physiol Rev. 2010;90:47-112.
Costanzo MR, Khayat R, Ponikowski P, Augostini R, Stellbrink C, Mianulli M, et al. Mechanisms and clinical consequences of untreated central sleep apnea in heart failure. J Am Coll Cardiol. 2015;65:72-84. doi: 10.1016/j.jacc.2014.10.025.
Pevernagie D, Sastry M, Vanderveken O. Treatment of respiratory sleep disorders. Regensburg: European Sleep Research Society; 2014.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol. 2016;69:1167. doi: 10.1016/j. rec.2016.11.005.
Ponikowski P, Javaheri S, Michalkiewicz D, Bart BA, Czarnecka D, Jastrzebski M, et al. Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure. Eur Heart J. 2012 ;33:889-94. doi: 10.1093/eurheartj/ehr298.
Costanzo MR, Augostini R, Goldberg LR, Ponikowski P, Stellbrink C, Javaheri S. Design of the remed® System Pivotal Trial: a prospective, randomized study in the use of respiratory rhythm management to treat central sleep apnea. J Card Fail. 2015;21: 892-902.
Ding N, Zhang X. Transvenous phrenic nerve stimulation, a novel therapeutic approach for central sleep apnea. J Thoracic Dis. 2018;10:2005- 10. doi: 10.21037/jtd.2018.03.59.
Javaheri S, Brown LK, Randerath WJ. Clinical applications of positive airway pressure therapy with adaptive servo-ventilation: part 2. Chest.2014;146:855-86.
Cowie MR, Woehrle H, Wegscheider K, Angermann C, d’Ortho MP, Erdmann E, et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med. 2015;373:1095–105. doi: 10.1056/NEJMoa1506459.
Brown LK, Javaheri S. Adaptive servo-ventilation for the treatment of central sleep apnea in congestive heart failure: What have we learned? Curr Opin Pulm Med. 2014;20:550-7. doi: 10.1097/MCP.0000000000000108.
Khayat R, Jarjoura D, Porter K, Sow A, Wannemacher J, Dohar R, et al. Sleep disordered breathing and post-discharge mortality in patients with acute heart failure. Eur Heart J. 2015;36:1463-9. doi: 10.1093/eurheartj/ ehu522.
Javaheri S. CPAP should not be used for central sleep apnea in congestive heart failure patients. J Clin Sleep Med. 2006;2:399-402.
Javaheri S, Brown LK, Randerath WJ. Positive airway pressure therapy with adaptive servoventilation: part 1: operational algorithms. Chest. 2014;146:514-23
Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE, et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation. 2010;121:1598-605. doi: 10.1161/CIRCULATIONAHA.109.902452.
Ferguson GT, Gilmartin M. CO2 rebreathing during BiPAP ventilatory assistance. Am J Respir Crit Care Med.1995;151:1126-35.
Schettino GP, Chatmongkolchart S, Hess DR. Kacmarek R.M. Position of exhalation port and mask design affect CO2 rebreathing during noninvasive positive pressure ventilation. Crit Care Med. 2003;31:2178-82.
Holanda MA, Reis RC, Winkeler GF, Fortaleza SC, Lima J.W. Pereira E. D.Influence of total face, facial and nasal masks on short-term adverse effects during noninvasive ventilation. J Bras Pneumol. 2009;35:164- 73.
Javaheri S. Kazemi H. Metabolic alkalosis and hypoventilation in humans. Am Rev Respir Dis. 1987;136:1011-16
Anderson LE, Henrich WL. Alkalemia-associated morbidity and mortality in medical and surgical patients. South Med J. 1987;80:729-33.
Yoshihisa A, Suzuki S, Yamaki T, Sugimoto K, Kunii H, Nakazato K, et al. Impact of adaptive servo-ventilation on cardiovascular function and prognosis in heart failure patients with preserved left ventricular ejection fraction and sleep-disordered breathing. Eur J Heart Fail. 2013;15:543–50. doi: 10.1093/eurjhf/hfs197.
Ortho M, Woehrle H. Current and future use of adaptive servo-ventilation. Eur Resp Pulm Dis. 2016;2:18-22.
Heider K, Arzt M, Lerzer C, Kolb L, Pfeifer M, Maier LS, et al. Adaptive servo-ventilation and sleep quality in treatment emergent central sleep apnea and central sleep apnea in patients with heart disease and preserved ejection fraction. Clin Res Cardiol. 2018;107:421-9. doi: 10.1007/s00392- 018-1203-9.
Bitter T, Westerheide N, Faber L, Hering D, Prinz C, Langer C, et al. Adaptive servoventilation in diastolic heart failure and Cheyne Stokes respiration. Eur Respir J. 2010;36:385-92. doi: 10.1183/09031936.00045609.
Lyons OD, Floras JS, Logan AG, Beanlands R, Cantolla JD, Fitzpatrick M, et al. Design of the effect of adaptive servo-ventilation on survival and cardiovascular hospital admissions in patients with heart failure and sleep apnoea: the ADVENT-HF trial. Eur J Heart Fail. 2017;19:579-87. doi: 10.1002/ejhf.790.
Tamisier R, Damy T, Davy J.M. Adaptive servoventilation (ASV) decreases unplanned hospitalizations in chronic heart failure (CHF) patients with central sleep apnoea (CSA): the French multicentre, prospective FACE cohort study. European Respiratory Society Congress 2015.
Davy JM, Tamisier R. Morbidity and mortality of Chronic Heart Failure (CHF) patients with Central Sleep Apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study. Eur Heart J. 2017; 38:1.
O’Connor CM, Whellan DJ, Fiuzat M, Punjabi NM, Tasissa G, Anstrom KJ, et al, Cardiovascular outcomes with minute ventilation- targeted adaptive servo-ventilation therapy in heart failure- The CAT-HF Trial. J J Am Coll Cardiol. 2017;69:1577-87. doi: 10.1016/j.jacc.2017.01.041
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
